As the ink dries on the US approval of Novartis' heart failure ... a comparator to Entresto. The drug has shown 20 per cent benefit over enalapril, so saying Entresto should cost 20 per cent ...

heart failure, and cancer are also expected to see lower out-of-pocket costs for these drugs," read a portion of the Biden ...

and Entresto, a treatment for heart failure. These medications currently cost $556 and $628, respectively. By lowering these costs, Medicare aims to improve access to essential treatments for ...

The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto's market exclusivity ... sale of a generic version of the heart failure blockbuster.

Eric Velazquez of Yale School of Medicine, the principal investigator in PIONEER-HF, said it is a “landmark study” and should mean that Entresto is used routinely “once acute heart failure ...

Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from ...